Related Experiment Video

Updated: Jul 7, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

Molecular events in the cardiomyopathy of sepsis

Michael A Flierl1, Daniel Rittirsch, Markus S Huber-Lang

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0602, United States of America.

Molecular Medicine (Cambridge, Mass.)
|February 8, 2008
PubMed

Insights

Septic cardiomyopathy, a complication of sepsis, involves complex molecular mechanisms impacting heart function. This study details current understanding of systemic, cellular, and supracellular pathways in sepsis-induced myocardial suppression.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Septic cardiomyopathy is a known complication of severe sepsis and septic shock.
  • The precise mechanisms driving septic cardiomyopathy remain incompletely understood.
  • Ongoing research aims to elucidate the pathophysiological pathways involved.

Purpose of the Study:

  • To synthesize the current understanding of molecular mechanisms underlying sepsis-induced myocardial suppression.
  • To provide an overview of systemic, supracellular, and cellular pathways involved.

Main Methods:

  • Review and synthesis of existing literature on septic cardiomyopathy.
  • Analysis of molecular mediators and cellular pathways implicated in myocardial dysfunction during sepsis.

Main Results:

  • Identified cardiosuppressive mediators contributing to septic cardiomyopathy.
  • Detailed alterations in myocardial calcium homeostasis, mitochondrial dysfunction, and apoptosis.
  • Elucidated the roles of nitric oxide and peroxynitrite in sepsis-induced cardiac dysfunction.

Conclusions:

  • Sepsis-induced myocardial suppression involves intricate systemic, supracellular, and cellular molecular mechanisms.
  • Further research into these pathways is crucial for understanding and treating septic cardiomyopathy.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...